IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
May 29, 2019 | 1 pm ET
Please join us for the first session of our webinar series exploring the benefits, trends and winning strategies for Gross-to-Net Automation. We begin this series by reiterating best practices and exploring modern options for automating and optimizing channel distribution datasets when setting pipeline and returns accruals as part of the broader gross-to-net process.
Jennifer Sharpe, Executive Advisor, Revenue Analytics Collaborative Melissa O’Neal, Executive Director, Product Management – Distribution Shivani Patel, Solutions Principal, Industry Solutions
During the webinar, we’ll explore the challenges Life Sciences manufacturers face when incorporating returns and pipeline inventory data into the GTN process. We’ll take a deep dive, examining how manufacturers can reduce potential misstatements of returns and pipeline liabilities due to the lack of triangulation with other channel and commercial data sets.
We’ll also review the different ways manufacturers are dealing with pipeline and returns data in their GTN process today including leading-edge automated GTN processes.
Then, we’ll walk through best practices for incorporating returns and retail data into a GTN process, including: